Toward a paradigm of protection through research: Earlier and more ethical inclusion of pregnant and breastfeeding women in clinical trials.

In its recent statement, the British Pharmacological Society has joined a global movement urging that pregnant and breastfeeding women should be protected not from research, but through it. Advancing this agenda marks a paradigm shift, emphasizing both the importance of the BPS endorsement and necessity of their ongoing engagement, especially to address the challenges of timely generation of evidence and the ethical complexities of early phase studies during pregnancy and breastfeeding.